Results 101 to 110 of about 676,789 (144)

Immune-Mediated IgA Nephropathy Induced by PD-1 Blockade in Extranodal NK/T-Cell Lymphoma. [PDF]

Int Med Case Rep J
Mohammadi N, Li F, Wang H, Mohammadi A, Wang L, Cong J.   +5 more
europepmc   +1 more source

PD-1/LAG-3 signaling rewires T-cells via MYC inhibition. [PDF]

Signal Transduct Target Ther
Chocarro L, Fernández-Rubio L, Ausin K, Blanco E, Echaide M, Vilaplana B, Santamaría E, Fernández-Irigoyen J, Kochan G, Escors D.   +9 more
europepmc   +1 more source

Anti-PD-1-induced bullous pemphigoid in a renal transplant recipient. [PDF]

SAGE Open Med Case Rep
Barnawi G, Kpata AJ, Aldibane R, Kashkari S, Lazarowitz R, Khanna M.   +5 more
europepmc   +1 more source

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report. [PDF]

Front Oncol
Li Y, Xia Y, Wang L, Liu X, Du Z.
europepmc   +1 more source

PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization. [PDF]

Cancer Discov
Deo A, Levin S, Buxbaum C, Benguigui M, Manobla B, Saar G, Bosak N, Bergmann E, Eran A, Grinfeld A, Harel M, Lahav C, Raviv Z, Daher S, Zer A, Reuter JH, Heuβel CP, Christopoulos P, Yizhak K, Shaked Y.   +19 more
europepmc   +1 more source

Bridging B-cell autoimmunity and oncology: the PD-1/PD-L1 paradox in systemic lupus erythematosus. [PDF]

Front Immunol
Guan Y, Chen C, Hou Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PD-1 and Autoimmunity

Critical Reviews™ in Immunology, 2011
An initiating T cell response requires both costimulatory signaling and T cell receptor/MHC binding. The immune system balances positive and negative costimulatory signal pathways to activate and deactivate T cells. This review focuses primarily on PD-1 and its ligands, which form a crucial inhibitory costimulatory pathway for maintaining peripheral ...
Shimpei, Kasagi, Seiji, Kawano, Shunichi, Kumagai   +2 more
openaire   +2 more sources